Ceftazidime exhibits a broad inhibition to the infection of SARS-CoV-2 prototype and Omicron variant in vitro by blocking spike protein-ACE2 interaction

MLA

Yun-zhe Zheng, et al. “Ceftazidime Exhibits a Broad Inhibition to the Infection of SARS-CoV-2 Prototype and Omicron Variant in Vitro by Blocking Spike Protein-ACE2 Interaction.” Acta Pharmacologica Sinica, Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........d228240d7033cc8f99f1a8018388a1fc&authtype=sso&custid=ns315887.

APA

Yun-zhe Zheng, Zhao-yuan Liu, Yue Li, Xiao-ying Lv, Yi Wu, Meng-wen Huang, Xing-chao Pan, Jian-feng Chen, & Chang-dong Lin. (2023). Ceftazidime exhibits a broad inhibition to the infection of SARS-CoV-2 prototype and Omicron variant in vitro by blocking spike protein-ACE2 interaction. Acta Pharmacologica Sinica.

Chicago

Yun-zhe Zheng, Zhao-yuan Liu, Yue Li, Xiao-ying Lv, Yi Wu, Meng-wen Huang, Xing-chao Pan, Jian-feng Chen, and Chang-dong Lin. 2023. “Ceftazidime Exhibits a Broad Inhibition to the Infection of SARS-CoV-2 Prototype and Omicron Variant in Vitro by Blocking Spike Protein-ACE2 Interaction.” Acta Pharmacologica Sinica, March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........d228240d7033cc8f99f1a8018388a1fc&authtype=sso&custid=ns315887.